Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels

Nitric Oxide - Biology and Chemistry

Volumn 46, Issue , 2015, Pages 131-144

  Tomasova, Lenka ^a,b   Pavlovicova, Michaela ^a   Malekova, Lubica ^a   Misak, Anton ^a   Kristek, Frantisek ^c   Grman, Marian ^a,c   Cacanyiova, Sona ^c   Tomasek, Milan ^d   Tomaskova, Zuzana ^a   Perry, Alexis ^e   Wood, Mark E ^e   Lacinova, Lubica ^a   Ondrias, Karol ^a   Whiteman, Matthew ^f  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d LOX Technologies   (Slovakia)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

AP39; Blood pressure; H2S; Nitric oxide deficiency; Pulse wave velocity

Indexed keywords

ANETHOLE; AP 39; APELIN; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL CAV3.3; CALCIUM CHANNEL T TYPE; ENDOTHELIN; HYDROGEN SULFIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PHOSPHONIUM DERIVATIVE; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG; UROTENSIN; ANETHOLE TRITHIONE; CAV3 PROTEIN, RAT; CAVEOLIN 3; ORGANOPHOSPHORUS COMPOUND; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DEPRESSED BLOOD PRESSURE; DERIVATIZATION; DIASTOLIC BLOOD PRESSURE; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART MUSCLE FIBER MEMBRANE; HEART RATE; HEMODYNAMIC PARAMETERS; HYPERTENSION; IC50; IN VITRO STUDY; IN VIVO STUDY; LIPID BILAYER; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; RAT; SARCOPLASMIC RETICULUM; SYMPATHETIC REFLEX; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANETHOLE TRITHIONE; ANIMALS; BLOOD PRESSURE; CAVEOLIN 3; HYDROGEN SULFIDE; NG-NITROARGININE METHYL ESTER; ORGANOPHOSPHORUS COMPOUNDS; PHENYLEPHRINE; PULSE WAVE ANALYSIS; RATS; RATS, WISTAR; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84925487695     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.12.012     Document Type: Article

References (100)

1. Y.H. Liu, M. Lu, L.F. Hu, P.T. Wong, G.D. Webb, and J.S. Bian Hydrogen sulfide in the mammalian cardiovascular system Antioxid. Redox Signal 17 2012 141 185
2. H. Kimura Production and physiological effects of hydrogen sulfide Antioxid. Redox Signal 20 2014 783 793
3. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase Science 322 2008 587 590
4. S. Mani, H. Li, A. Untereiner, L. Wu, G. Yang, and R.C. Austin Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis Circulation 127 2013 2523 2534
5. M. Whiteman, K.M. Gooding, J.L. Whatmore, C.I. Ball, D. Mawson, and K. Skinner Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide Diabetologia 53 2010 1722 1726
6. S.K. Jain, R. Bull, J.L. Rains, P.F. Bass, S.N. Levine, and S. Reddy Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid. Redox Signal 12 2010 1333 1337
7. 2S) - the third gas of interest for pharmacologists Pharmacol. Rep 59 2007 4 24
8. 2S and cellular proliferation and apoptosis Sheng Li Xue Bao 59 2007 133 140
9. R. Wang Physiological implications of hydrogen sulfide: a whiff exploration that blossomed Physiol. Rev 92 2012 791 896
10. L.L. Pan, X.H. Liu, Q.H. Gong, H.B. Yang, and Y.Z. Zhu Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid. Redox Signal 17 2012 106 118
11. J.W. Calvert, W.A. Coetzee, and D.J. Lefer Novel insights into hydrogen sulfide-mediated cytoprotection Antioxid. Redox Signal 12 2010 1203 1217
12. 2S generated by heart in rat and its effects on cardiac function Biochem. Biophys. Res. Commun 313 2004 362 368
13. L. Chang, B. Geng, F. Yu, J. Zhao, H. Jiang, and J. Du Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats Amino Acids 34 2008 573 585
14. B. Geng, L. Chang, C. Pan, Y. Qi, J. Zhao, and Y. Pang Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol Biochem. Biophys. Res. Commun 318 2004 756 763
15. ATP channels Basic Res. Cardiol 101 2006 53 60
16. Y.Z. Zhu, Z.J. Wang, P. Ho, Y.Y. Loke, Y.C. Zhu, and S.H. Huang Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats J. Appl. Physiol 102 2007 261 268
17. 3K/Akt pathways Pflugers Arch 455 2008 607 616
18. T.T. Pan, Z.N. Feng, S.W. Lee, P.K. Moore, and J.S. Bian Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes J. Mol. Cell. Cardiol 40 2006 119 130
19. Y. Ji, Q.F. Pang, G. Xu, L. Wang, J.K. Wang, and Y.M. Zeng Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury Eur. J. Pharmacol 587 2008 1 7
20. L. Li, M. Whiteman, Y.Y. Guan, K.L. Neo, Y. Cheng, and S.W. Lee Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide Circulation 117 2008 2351 2360
21. -/- mice Br. J. Pharmacol 169 2013 1795 1809
22. 2+ signaling during terminal differentiation (fusion) of human myoblasts Proc. Natl. Acad. Sci. U.S.A. 97 2000 7627 7632
23. 2+ channels Science 302 2003 1416 1418
24. L. Lacinova Voltage-dependent calcium channels Gen. Physiol. Biophys 24 Suppl. 1 2005 1 78
25. B. Nilius, K. Talavera, and A. Verkhratsky T-type calcium channels: the never ending story Cell Calcium 40 2006 81 88
26. I.Y. Kuo, S.E. Wolfle, and C.E. Hill T-type calcium channels and vascular function: the new kid on the block? J. Physiol 589 2011 783 795
27. v3.1 activity in cardiac myocytes through protein kinase A PLoS ONE 7 2012 e39965
28. Y.M. Shuba, E. Perez-Reyes, P. Lory, and J. Noebels T-type calcium channels: from discovery to channelopathies, 25 years of research Channels (Austin) 2 2008 299 302
29. C. Peers, C.C. Bauer, J.P. Boyle, J.L. Scragg, and M.L. Dallas Modulation of ion channels by hydrogen sulfide Antioxid. Redox Signal 17 2012 95 105
30. A.R. Marks Calcium and the heart: a question of life and death J. Clin. Invest 111 2003 597 600
31. A.M. Gomez, H.H. Valdivia, H. Cheng, M.R. Lederer, L.F. Santana, and M.B. Cannell Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure Science 276 1997 800 806
32. 2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure Cardiovasc. Res 44 1999 146 155
33. 2+ leak: a novel therapeutic target in heart failure Circulation 111 2005 3342 3346
34. M.J. Bround, P. Asghari, R.B. Wambolt, L. Bohunek, C. Smits, and M. Philit Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice Cardiovasc. Res 96 2012 372 380
35. 2+ sparks Am. J. Physiol. Heart Circ. Physiol 304 2013 H1446 H1454
36. Y.P. Zhang, H. Zhang, and D.D. Duan Chloride channels in stroke Acta Pharmacol. Sin 34 2013 17 23
37. C. Yang, Y.W. Kwan, S.W. Chan, S.M. Lee, and G.P. Leung Potentiation of EDHF-mediated relaxation by chloride channel blockers Acta Pharmacol. Sin 31 2010 1303 1311
38. E. Colding-Jørgensen Phenotypic variability in myotonia congenita Muscle Nerve 32 2005 19 34
39. D.D. Duan Volume matters: novel roles of the volume-regulated CLC-3 channels in hypertension-induced cerebrovascular remodeling Hypertension 56 2010 346 348
40. D.D. Duan The ClC-3 chloride channels in cardiovascular disease Acta Pharmacol. Sin 32 2011 675 684
41. D.D. Duan Phenomics of cardiac chloride channels Compr. Physiol 3 2013 667 692
42. - donor NaHS inhibits intracellular chloride channels Gen. Physiol. Biophys 28 2009 190 194
43. K. Wang, S. Ahmad, M. Cai, J. Rennie, T. Fujisawa, and F. Crispi Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia Circulation 127 2013 2514 2522
44. B.L. Predmore, and D.J. Lefer Development of hydrogen sulfide-based therapeutics for cardiovascular disease J. Cardiovasc. Transl. Res 3 2010 487 498
45. 2S-releasing drugs as pharmaceuticals J. Med. Chem 53 2010 6275 6286
46. M.V. Chan, and J.L. Wallace Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments Am. J. Physiol. Gastrointest. Liver Physiol 305 2013 G467 G473
47. S. Le Trionnaire, A. Perry, B. Szczesny, C. Szabo, P.G. Winyard, and J.L. Whatmore The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl) triphenylphosphonium bromide (AP39) Med. Chem. Comm 5 2014 728 736
48. B. Szczesny, K. Módis, K. Yanagi, C. Coletta, S. Le Trionnaire, and A. Perry AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro Nitric Oxide 41 2014 120 130
49. C. Kilkenny, W. Browne, I.C. Cuthill, M. Emerson, D.G. Altman N.C.R.R.G.W. Group Animal research: reporting in vivo experiments - the ARRIVE guidelines Br. J. Pharmacol 160 2010 1577 1579
50. S.S. Lee, D.H. Nam, Y.S. Hong, W.B. Lee, I.H. Son, and K.H. Kim Measurement of blood pressure using an arterial pulsimeter equipped with a Hall device Sensors (Basel) 11 2011 1784 1793
51. M. Frimodt-Møller, A.L. Kamper, S. Strandgaard, S. Kreiner, and A.H. Nielsen Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease - a randomized trial PLoS ONE 7 2012 e41757
52. N. Klugbauer, E. Marais, L. Lacinova, and F. Hofmann A T-type calcium channel from mouse brain Pflugers Arch 437 1999 710 715
53. J.H. Lee, A.N. Daud, L.L. Cribbs, A.E. Lacerda, A. Pereverzev, and U. Klockner Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family J. Neurosci 19 1999 1912 1921
54. 2+ channel gene family Circ. Res 83 1998 103 109
55. M. Kurejova, B. Uhrik, Z. Sulova, B. Sedlakova, O. Krizanova, and L. Lacinova Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line Eur. J. Pharmacol 567 2007 10 18
56. M. Drigelova, B. Tarabova, G. Duburs, and L. Lacinova The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents Can. J. Physiol. Pharmacol 87 2009 923 932
57. E.D. Buck, W.G. Lachnit, and I.N. Pessah Mechanisms of delta-hexachlorocyclohexane toxicity: I. Relationship between altered ventricular myocyte contractility and ryanodine receptor function J. Pharmacol. Exp. Ther 289 1999 477 485
58. 2 J. Membr. Biol 212 2006 17 28
59. S.O. Marx, J. Gaburjakova, M. Gaburjakova, C. Henrikson, K. Ondrias, and A.R. Marks Coupled gating between cardiac calcium release channels (ryanodine receptors) Circ. Res 88 2001 1151 1158
60. K.A. Hayman, T.D. Spurway, and R.H. Ashley Single anion channels reconstituted from cardiac mitoplasts J. Membr. Biol 136 1993 181 190
61. A.J. King, J.M. Pfeffer, M.A. Pfeffer, and B.M. Brenner Systemic hemodynamic effects of endothelin in rats Am. J. Physiol 258 1990 H787 H792
62. S.M. Gardiner, J.E. March, P.A. Kemp, and T. Bennett Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response Br. J. Pharmacol 143 2004 422 430
63. C.J. Charles, M.T. Rademaker, and A.M. Richards Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep J. Endocrinol 189 2006 701 710
64. M. Whiteman, S. Le Trionnaire, M. Chopra, B. Fox, and J. Whatmore Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools Clin. Sci 121 2011 459 488
65. H. Yan, J. Du, and C. Tang The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats Biochem. Biophys. Res. Commun 313 2004 22 27
66. D.J. Polhemus, J.W. Calvert, J. Butler, and D.J. Lefer The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failure Scientifica 2014 2014 768607
67. J.W. Elrod, J.W. Calvert, J. Morrison, J.E. Doeller, D.W. Kraus, and L. Tao Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function Proc. Natl. Acad. Sci. U.S.A. 104 2007 15560 15565
68. J.C. Mathai, A. Missner, P. Kugler, S.M. Saparov, M.L. Zeidel, and J.K. Lee No facilitator required for membrane transport of hydrogen sulfide Proc. Natl. Acad. Sci. U.S.A. 106 2009 16633 16638
69. M. Whiteman, L. Li, I. Kostetski, S.H. Chu, J.L. Siau, and M. Bhatia Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide Biochem. Biophys. Res. Commun 343 2006 303 310
70. - donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells Pflugers Arch 457 2008 271 279
71. - induced NO release from S-nitrosoglutathione Biochem. Biophys. Res. Commun 390 2009 1241 1244
72. 2S action Curr. Pharm. Biotechnol 12 2011 1394 1405
73. 2S in coupled sulphide-nitroso signalling pathway Gen. Physiol. Biophys 29 2010 402 410
74. Q.C. Yong, L.F. Hu, S. Wang, D. Huang, and J.S. Bian Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl Cardiovasc. Res 88 2010 482 491
75. C. Coletta, A. Papapetropoulos, K. Erdelyi, G. Olah, K. Modis, and P. Panopoulos Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation Proc. Natl. Acad. Sci. U.S.A. 109 2012 9161 9166
76. 2S and S-nitrosothiols J. Am. Chem. Soc 134 2012 12016 12027
77. •NO release Gen. Physiol. Biophys 32 2013 429 441
78. M.M. Cortese-Krott, B.O. Fernandez, J.L. Santos, E. Mergia, M. Grman, and P. Nagy Nitrosopersulfide (SSNO-) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide Redox Biol 2 2014 234 244
79. J. Blacher, R. Asmar, S. Djane, G.M. London, and M.E. Safar Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients Hypertension 33 1999 1111 1117
80. R.M. Fitch, R. Vergona, M.E. Sullivan, and Y.X. Wang Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats Cardiovasc. Res 51 2001 351 358
81. 2+ channel Acta Physiol 207 2013 709 720
82. 2+: think locally, act globally Microcirculation 20 2013 279 280
83. V3.2 Am. J. Physiol. Lung Cell. Mol. Physiol 305 2013 L154 L164
84. 2+ channels through cGMP/PKG signaling Am. J. Physiol. Heart Circ. Physiol 306 2014 H279 H285
85. 2+ channels in rat cerebral arterial smooth muscle J. Cell Sci 126 2013 2944 2954
86. 2+ channels in cerebral arteries: approaches, hypotheses, and speculation Microcirculation 20 2013 299 306
87. 2+ channels in rat cerebral arteries: role in myogenic tone development Am. J. Physiol. Heart Circ. Physiol 304 2013 H58 H71
88. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs J. Pharmacol. Exp. Ther 328 2009 621 627
89. V3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain Pain 150 2010 183 191
90. 2+ channels in the rat and mouse thalamus J. Physiol 574 2006 415 430
91. S.M. Todorovic, V. Jevtovic-Todorovic, A. Meyenburg, S. Mennerick, E. Perez-Reyes, and C. Romano Redox modulation of T-type calcium channels in rat peripheral nociceptors Neuron 31 2001 75 85
92. 2+ channels by hydrogen sulfide Nitric Oxide 31 Suppl. 2 2013 S27 S28
93. S.O. Marx, and A.R. Marks Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases J. Mol. Cell. Cardiol 58 2013 225 231
94. D.G. Welsh, M.T. Nelson, D.M. Eckman, and J.E. Brayden Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure J. Physiol 527 Pt 1 2000 139 148
95. - channels Gen. Pharmacol 27 1996 1131 1140
96. W.F. Jackson Ion channels and vascular tone Hypertension 35 2000 173 178
97. 2+ ATPase as a therapeutic target for heart failure Expert Opin. Biol. Ther 10 2010 29 41
98. Y. Kimura, R. Dargusch, D. Schubert, and H. Kimura Hydrogen sulfide protects HT22 neuronal cells from oxidative stress Antioxid. Redox Signal 8 2006 661 670
99. 2+ from an intracellular store in rat pulmonary artery smooth muscle cells Br. J. Pharmacol 140 2003 1442 1450
100. Z.J. Song, M.Y. Ng, Z.W. Lee, W. Dai, T. Hagen, and P.K. Moore Hydrogen sulfide donors in research and drug development, Med Chem. Comm 5 2014 557 570